PAIGE BOLES: Open Payments
NPI 1154810612 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 96 payments from 24 companies in 2025. Trend: 2023 $1,855 · 2024 $1,397 · 2025 $1,660
Food & beverage: $1,660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $224 |
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Amgen Inc. | 10 | $149 |
| Viatris Specialty LLC | 8 | $145 |
| Lilly USA, LLC | 9 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $128 |
| Novo Nordisk Inc | 6 | $105 |
| Lundbeck LLC | 4 | $77 |
| Sumitomo Pharma America, Inc. | 4 | $68 |
| PFIZER INC. | 4 | $66 |
Products named: YUPELRI, QULIPTA, Kerendia, AIRSUPRA, OTEZLA, JARDIANCE, REXULTI, MOUNJARO.
Industry payments across AR — which companies pay providers there.
